AbbVie

Pharma

AbbVie plots $10B US outlay as pharma tariff threat looms

With the threat of drug tariffs sparking an investment rush in the U.S., AbbVie is laying plans to spend billions in the country over the next decade.

Fraiser Kansteiner Apr 25, 2025 11:52am

AstraZeneca returns to industry association PhRMA

Apr 22, 2025 4:34pm

Top 20 pharma companies by 2024 revenue

Apr 21, 2025 3:00am

Novo’s Wegovy, J&J’s Tremfya led March TV ad spending totals

Apr 7, 2025 11:21am

Novo, Merck, Hengrui-Elevar—Fierce Pharma Asia

Mar 28, 2025 9:28am

AbbVie’s Rinvoq, Skyrizi regain TV ad spending lead in February

Mar 12, 2025 10:53am